Briefing paper on Value Based Pricing and Cancer Drugs Fund

On 20th September 2013, Cancer52 published Briefing Papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF); alongside an introductory debate on the topic among leading experts from within the Cancer52 family.